Your browser doesn't support javascript.
loading
Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network.
Du, Zhonghua; Wen, Xue; Wang, Yichen; Jia, Lin; Zhang, Shilin; Liu, Yudi; Zhou, Lei; Li, Hui; Yang, Wang; Wang, Cong; Chen, Jingcheng; Hao, Yajing; Salgado Figueroa, Daniela; Chen, Huiling; Li, Dan; Chen, Naifei; Celik, Ilkay; Zhu, Yanbo; Yan, Zi; Fu, Changhao; Liu, Shanshan; Jiao, Benzheng; Wang, Zhuo; Zhang, Hui; Gülsoy, Günhan; Luo, Jianjun; Qin, Baoming; Gao, Sujun; Kapranov, Philipp; Esteban, Miguel A; Zhang, Songling; Li, Wei; Ay, Ferhat; Chen, Runsheng; Hoffman, Andrew R; Cui, Jiuwei; Hu, Ji-Fan.
Afiliação
  • Du Z; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Wen X; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Wang Y; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Jia L; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Zhang S; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Liu Y; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Zhou L; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Li H; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Yang W; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Wang C; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Chen J; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Hao Y; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Salgado Figueroa D; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Chen H; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Li D; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Chen N; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Celik I; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Zhu Y; CAS Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, People's Republic of China.
  • Yan Z; La Jolla Institute for Allergy and Immunology, La Jolla, California, 92037, USA.
  • Fu C; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Liu S; Department of Endocrinology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
  • Jiao B; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Wang Z; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Zhang H; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Gülsoy G; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Luo J; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Qin B; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Gao S; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Kapranov P; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Esteban MA; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Zhang S; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Li W; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Ay F; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Chen R; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, First Hospital, Jilin University, Changchun, Jilin, 130061, People's Republic of China.
  • Hoffman AR; Stanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
  • Cui J; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, 510530, People's Republic of China.
  • Hu JF; Google Inc., Mountain View, CA, 94043, USA.
Genome Biol ; 22(1): 233, 2021 08 19.
Article em En | MEDLINE | ID: mdl-34412677
ABSTRACT

BACKGROUND:

A specific 3-dimensional intrachromosomal architecture of core stem cell factor genes is required to reprogram a somatic cell into pluripotency. As little is known about the epigenetic readers that orchestrate this architectural remodeling, we used a novel chromatin RNA in situ reverse transcription sequencing (CRIST-seq) approach to profile long noncoding RNAs (lncRNAs) in the Oct4 promoter.

RESULTS:

We identify Platr10 as an Oct4 - Sox2 binding lncRNA that is activated in somatic cell reprogramming. Platr10 is essential for the maintenance of pluripotency, and lack of this lncRNA causes stem cells to exit from pluripotency. In fibroblasts, ectopically expressed Platr10 functions in trans to activate core stem cell factor genes and enhance pluripotent reprogramming. Using RNA reverse transcription-associated trap sequencing (RAT-seq), we show that Platr10 interacts with multiple pluripotency-associated genes, including Oct4, Sox2, Klf4, and c-Myc, which have been extensively used to reprogram somatic cells. Mechanistically, we demonstrate that Platr10 helps orchestrate intrachromosomal promoter-enhancer looping and recruits TET1, the enzyme that actively induces DNA demethylation for the initiation of pluripotency. We further show that Platr10 contains an Oct4 binding element that interacts with the Oct4 promoter and a TET1-binding element that recruits TET1. Mutation of either of these two elements abolishes Platr10 activity.

CONCLUSION:

These data suggest that Platr10 functions as a novel chromatin RNA molecule to control pluripotency in trans by modulating chromatin architecture and regulating DNA methylation in the core stem cell factor network.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Células-Tronco Pluripotentes / Reprogramação Celular / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Genome Biol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Células-Tronco Pluripotentes / Reprogramação Celular / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Genome Biol Ano de publicação: 2021 Tipo de documento: Article